You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-pan-AKT (phospho T308) antibody (ab38449)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab38449? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab38449 has been referenced in 5 publications.

  1. Fleming GF et al. Phase II trial of temsirolimus in patients with metastatic breast cancer. Breast Cancer Res Treat : (2012). PubMed: 22245973
  2. Hafner C et al. Activation of the PI3K/AKT pathway in Merkel cell carcinoma. PLoS One 7:e31255 (2012). IHC-P; Human. PubMed: 22363598
  3. Nickkho-Amiry M et al. Peroxisome proliferator-activated receptors modulate proliferation and angiogenesis in human endometrial carcinoma. Mol Cancer Res 10:441-53 (2012). WB; Human. PubMed: 22205725
  4. Hartz AM et al. Estrogen receptor beta signaling through phosphatase and tensin homolog/phosphoinositide 3-kinase/Akt/glycogen synthase kinase 3 down-regulates blood-brain barrier breast cancer resistance protein. J Pharmacol Exp Ther 334:467-76 (2010). WB; Rat. PubMed: 20460386
  5. Wagner M et al. Selective expansion of the {beta}-cell compartment in the pancreas of keratinocyte growth factor transgenic mice. Am J Physiol Gastrointest Liver Physiol : (2008). PubMed: 18372394

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"